Neuroplast is a medical biotechnology company specialized in regenerative medicine. It focuses on bringing autologous stem cell products to the global market environment addressing short track programs (from bench to bedside). The company develops therapeutic strategies, which slow down or stop inflammatory and/or apoptotic processes, an unmet need in acute and chronic idiopathic, traumatic and/ or ischemic neurodegenerative disorders.